Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration

NCT07040137 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Spinocerebellar Degeneration

Interventions

DRUG: KPS-0373
DRUG: Placebo

Sponsor

Kissei Pharmaceutical Co., Ltd.